All Stories

  1. The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension

    Article • Annals of the American Thoracic Society, June 2016, American Thoracic Society

    Dr Stephen C Mathai

  2. Quality of life in patients with chronic thromboembolic pulmonary hypertension

    Article • European Respiratory Journal, April 2016, European Respiratory Society (ERS)

    Dr Stephen C Mathai

  3. Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension

    Article • Arthritis & Rheumatology, February 2016, Wiley

    Dr Stephen C Mathai

  4. Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension

    Article • Annals of the American Thoracic Society, January 2016, American Thoracic Society

    Dr Stephen C Mathai, David Lederer

  5. Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension

    Article • Annals of the American Thoracic Society, January 2016, American Thoracic Society

    Dr Stephen C Mathai

  6. Measuring Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Not on Active Treatment (MOTION): A Study of the Effects of Riociguat on Patient-Reported Outcomes and an Exploration of Telemetric Technology in PAH

    Article • CHEST Journal, October 2015, Elsevier

    Dr Stephen C Mathai

  7. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia

    Article • The Laryngoscope, September 2015, Wiley

    Dr Stephen C Mathai

  8. Exercise Echocardiography in Connective Tissue Disease∗

    Article • Journal of the American College of Cardiology, July 2015, Elsevier

    Dr Stephen C Mathai

  9. Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes

    Article • Pulmonary Circulation, June 2015, University of Chicago Press

    Dr Stephen C Mathai

  10. Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension

    Article • American Review of Respiratory Disease, March 2015, American Thoracic Society

    Dr Stephen C Mathai

  11. Sex Differences in Response to Tadalafil in Pulmonary Arterial Hypertension

    Article • CHEST Journal, January 2015, Elsevier

    Dr Stephen C Mathai

  12. Severity of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension in African Americans

    Article • Medicine, July 2014, Wolters Kluwer Health

    Dr Stephen C Mathai

  13. What Costs Can a U.S. Health Plan Expect if an Enrollee Has Chronic Thromboembolic Pulmonary Hypertension? A Guideline-Based Estimate of Healthcare Resource Use and Cost

    Article • CHEST Journal, March 2014, Elsevier

    Dr Stephen C Mathai

  14. Guideline Based Estimates of Diagnostic and Treatment-Related Resource Use and Costs of a Typical Pulmonary Arterial Hypertension Patient to U.S. Health Plan

    Article • CHEST Journal, March 2014, Elsevier

    Dr Stephen C Mathai

  15. Pulmonary Hypertension Associated with Connective Tissue Disease

    Article • January 2014, Springer Science + Business Media

    Dr Stephen C Mathai

  16. Chronic Expanding Hematoma of the Lung

    Article • American Review of Respiratory Disease, December 2013, American Thoracic Society

    Dr Stephen C Mathai

  17. Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

    Article • Arthritis & Rheumatism, November 2013, Wiley

    Dr Stephen C Mathai

  18. Combined Pulmonary Fibrosis and Emphysema Among Patients With Scleroderma-Associated Pulmonary Hypertension

    Article • CHEST Journal, October 2013, Elsevier

    Dr Stephen C Mathai

  19. A Look to the Past, Present, and Future of Pulmonary Hypertension

    Article • International Journal of Clinical Practice, April 2013, Wiley

    Dr Stephen C Mathai

  20. Comparison of Moderate versus Deep Sedation for Endobronchial Ultrasound Transbronchial Needle Aspiration

    Article • Annals of the American Thoracic Society, April 2013, American Thoracic Society

    Dr Stephen C Mathai

  21. Reply: A Call to Apply the Minimal Important Difference in Pulmonary Arterial Hypertension beyond the Flawed 6-Minute-Walk Test

    Article • American Review of Respiratory Disease, March 2013, American Thoracic Society

    Dr Stephen C Mathai

  22. Solvitur Ambulando…or Maybe Not?

    Article • CHEST Journal, February 2013, Elsevier

    Dr Stephen C Mathai

  23. Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients

    Article • Health and Quality of Life Outcomes, January 2013, Springer Science + Business Media

    Dr Stephen C Mathai

  24. Regional and Global Biventricular Function in Pulmonary Arterial Hypertension: A Cardiac MR Imaging Study

    Article • Radiology, January 2013, Radiological Society of North America (RSNA)

    Dr Stephen C Mathai

  25. Pulmonary hypertension topics

    Article • Expert Review of Respiratory Medicine, October 2012, Taylor & Francis

    Dr Stephen C Mathai

  26. A Beginning’s End

    Article • International Journal of Clinical Practice, September 2012, Wiley

    Dr Stephen C Mathai

  27. The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension

    Article • American Review of Respiratory Disease, September 2012, American Thoracic Society

    Dr Stephen C Mathai

  28. Pulmonary Arterial Hypertension in Connective Tissue Diseases

    Article • Heart Failure Clinics, July 2012, Elsevier

    Dr Stephen C Mathai

  29. Pulmonary Arterial Hypertension: MR Imaging-derived First-Pass Bolus Kinetic Parameters Are Biomarkers for Pulmonary Hemodynamics, Cardiac Function, and Ventricular Remodeling

    Article • Radiology, June 2012, Radiological Society of North America (RSNA)

    Dr Stephen C Mathai

  30. Macrophage Migration Inhibitory Factor (MIF) Promoter Polymorphisms Are Associated With Favorable Hemodynamic Indices In Pulmonary Arterial Hypertension

    Article • May 2012, American Thoracic Society

    Dr Stephen C Mathai

  31. Gene Expression In The Neurohormonal Axis And Disease Severity In Treatment-Naive Scleroderma-Related Pulmonary Arterial Hypertension

    Article • May 2012, American Thoracic Society

    Dr Stephen C Mathai

  32. The Minimal Important Difference For The Six Minute Walk Test In Patients With Pulmonary Arterial Hypertension

    Article • May 2012, American Thoracic Society

    Dr Stephen C Mathai

  33. Epigenetic Regulations And Metabolic Abnormalities In Scleroderma-Associated Pulmonary Arterial Hypertension

    Article • May 2012, American Thoracic Society

    Dr Stephen C Mathai

  34. Cardiac MRI (cMRI) As A Screening Tool For Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (PAH-SSc)

    Article • May 2012, American Thoracic Society

    Dr Stephen C Mathai

  35. Assessment Of Tricuspid Annular Plane Systolic Excursion (TAPSE) By 2D And M-Mode Echocardiography In Pulmonary Arterial Hypertension Patients

    Article • May 2012, American Thoracic Society

    Dr Stephen C Mathai

  36. The cost to managed care of managing pulmonary hypertension

    Article • Journal of Medical Economics, January 2012, Informa Healthcare

    Dr Stephen C Mathai

  37. Increased Right Ventricular Septomarginal Trabeculation Mass is a Novel Marker for Pulmonary Hypertension

    Article • Investigative Radiology, September 2011, Wolters Kluwer Health

    Dr Stephen C Mathai

  38. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies

    Article • Arthritis & Rheumatism, August 2011, Wiley

    Dr Stephen C Mathai, Professor Olivier SITBON

  39. Serum Macrophage Migration Inhibitory Factor (MIF) Is Increased In Patients With Pulmonary Arterial Hypertension

    Article • May 2011, American Thoracic Society

    Dr Stephen C Mathai

  40. Exhaled Nitric Oxide In Scleroderma Patients Without Pulmonary Involvement

    Article • May 2011, American Thoracic Society

    Dr Stephen C Mathai

  41. Tricuspid Annular Plane Systolic Excursion In Idiopathic Versus Scleroderma-Related Pulmonary Arterial Hypertension

    Article • May 2011, American Thoracic Society

    Dr Stephen C Mathai

  42. The Relationship Between NT-ProBNP And Right Ventricular Function In Pulmonary Arterial Hypertension

    Article • May 2011, American Thoracic Society

    Dr Stephen C Mathai

  43. Bi-Ventricular Regional Function In Relation To Global Function And Hemodynamics In Pulmonary Hypertension: A Cardiac MRI Study

    Article • May 2011, American Thoracic Society

    Dr Stephen C Mathai

  44. Pulmonary Arterial Hypertension: First-Pass Contrast Bolus Kinetics Contain Information On RV Function, Remodeling, And Lung Resistance

    Article • May 2011, American Thoracic Society

    Dr Stephen C Mathai

  45. Pulmonary arterial hypertension associated with systemic sclerosis

    Article • Expert Review of Respiratory Medicine, April 2011, Taylor & Francis

    Dr Stephen C Mathai

  46. Myocardial Delayed Enhancement in Pulmonary Hypertension: Pulmonary Hemodynamics, Right Ventricular Function, and Remodeling

    Article • American Journal of Roentgenology, January 2011, American Roentgen Ray Society

    Dr Stephen C Mathai

  47. Cardiac complications of systemic sclerosis: recent progress in diagnosis

    Article • Current Opinion in Rheumatology, November 2010, Wolters Kluwer Health

    Dr Stephen C Mathai

  48. Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?

    Article • CHEST Journal, August 2010, Elsevier

    Dr Stephen C Mathai

  49. Renal Dysfunction In Patients With Scleroderma-associated Pulmonary Arterial Hypertension: Severity And Impact On Outcomes

    Article • May 2010, American Thoracic Society

    Dr Stephen C Mathai

  50. The Impact Of Health-Related Quality Of Life On Outcomes In Pulmonary Arterial Hypertension

    Article • May 2010, American Thoracic Society

    Dr Stephen C Mathai

  51. Characteristics And Survival Of African-American Patients With Pulmonary Hypertension Associated With Scleroderma

    Article • May 2010, American Thoracic Society

    Dr Stephen C Mathai

  52. Epigenetic Modification Of Circulating Lymphocytes In Pulmonary Arterial Hypertension

    Article • May 2010, American Thoracic Society

    Dr Stephen C Mathai

  53. Effect Of Pulmonary Arterial Hypertension On Transcriptomics Of Peripheral Blood Mononuclear Cells

    Article • May 2010, American Thoracic Society

    Dr Stephen C Mathai

  54. Prognostic Value Of Percent Predicted Six Minute Walk Test Distance In Idiopathic Pulmonary Arterial Hypertension Patients: An Analysis Of The REVEAL Registry

    Article • May 2010, American Thoracic Society

    Dr Stephen C Mathai

  55. Combined Pulmonary Hypertension (PH) And Interstitial Lung Disease In Systemic Sclerosis: The Role Of PH Therapy

    Article • May 2010, American Thoracic Society

    Dr Stephen C Mathai

  56. Scleroderma Lung Disease

    Article • Clinical Reviews in Allergy & Immunology, January 2010, Springer Science + Business Media

    Dr Stephen C Mathai

  57. Survival in Systemic Sclerosis–related Pulmonary Arterial Hypertension in the Modern Treatment Era

    Article • American Review of Respiratory Disease, December 2009, American Thoracic Society

    Dr Stephen C Mathai

  58. Therapy for pulmonary arterial hypertension associated with systemic sclerosis

    Article • Current Opinion in Rheumatology, November 2009, Wolters Kluwer Health

    Dr Stephen C Mathai

  59. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung disease

    Article • Arthritis & Rheumatism, February 2009, Wiley

    Dr Stephen C Mathai

  60. Sleep Quality and Health-Related Quality of Life in Idiopathic Pulmonary Fibrosis

    Article • CHEST Journal, October 2008, Elsevier

    Dr Stephen C Mathai

  61. Hyponatremia Predicts Right Heart Failure and Poor Survival in Pulmonary Arterial Hypertension

    Article • American Review of Respiratory Disease, June 2008, American Thoracic Society

    Dr Stephen C Mathai

  62. Identification of candidate genes in scleroderma-related pulmonary arterial hypertension

    Article • Translational Research, April 2008, Elsevier

    Dr Stephen C Mathai

  63. Pulmonary Hypertension Related to Respiratory Disease

    Article • Clinical Pulmonary Medicine, September 2007, Wolters Kluwer Health

    Dr Stephen C Mathai

  64. Pulmonary Hypertension Associated with Chronic Respiratory Disease

    Article • Clinics in Chest Medicine, March 2007, Elsevier

    Dr Stephen C Mathai

  65. TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION PREDICTS MORTALITY IN PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH SCLERODERMA

    Article • CHEST Journal, October 2006, Elsevier

    Dr Stephen C Mathai

  66. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

    Article • Arthritis & Rheumatism, January 2006, Wiley

    Dr Stephen C Mathai

  67. The Questionable Efficacy of Pirfenidone in IPF

    Article • American Review of Respiratory Disease, November 2005, American Thoracic Society

    Dr Stephen C Mathai

  68. THE ADDITION OF SILDENAFIL TO BOSENTAN THERAPY IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

    Article • CHEST Journal, October 2005, Elsevier

    Dr Stephen C Mathai

  69. Long-Term Outcome of Bosentan Treatment in Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated with the Scleroderma Spectrum of Diseases

    Article • The Journal of Heart and Lung Transplantation, October 2005, Elsevier

    Dr Stephen C Mathai

  70. Faculty of 1000 evaluation for Iron deficiency is common in idiopathic pulmonary arterial hypertension.

    Article • Faculty of 1000, Ltd.

    Dr Stephen C Mathai

  71. Faculty of 1000 evaluation for Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension.

    Article • Faculty of 1000, Ltd.

    Dr Stephen C Mathai

  72. Faculty of 1000 evaluation for Long-term outcome with intravenous iloprost in pulmonary arterial hypertension.

    Article • Faculty of 1000, Ltd.

    Dr Stephen C Mathai

  73. Faculty of 1000 evaluation for Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.

    Article • Faculty of 1000, Ltd.

    Dr Stephen C Mathai

  74. Faculty of 1000 evaluation for Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.

    Article • Faculty of 1000, Ltd.

    Dr Stephen C Mathai